FDA Approves First in Class Targeted Therapy for Metastatic Pancreatic Cancer
The U.S. Food and Drug Administration today approved Rasonque (daraxonrasib), a RAS inhibitor for the most common form of pancreatic…
Regulatory Approvals
FDA Approves Drug for Pancreatic Cancer in Milestone for Treatment of Deadly Disease
FDA Approves Drug for Pancreatic Cancer in Milestone for Treatment of Deadly Disease WSJ
FDA Approves Daraxonrasib for Metastatic Pancreatic Adenocarcinoma
FDA Approves Daraxonrasib for Metastatic Pancreatic Adenocarcinoma The ASCO Post
Jazz secures FDA approval for Ziihera in advanced HER2+ GEA
Jazz secures FDA approval for Ziihera in advanced HER2+ GEA Pharmaceutical Technology
FDA Approves Continuous Glucose + Ketone Monitor Device
FDA Approves Continuous Glucose + Ketone Monitor Device Medscape